Cargando…
Looking ahead at the potential benefits of biotechnology-derived allergen therapeutics
While biotechnology-derived allergen therapeutics show promise in improving the safety of immunotherapy, they may prove to have additional benefits in comparison to conventional allergenic extracts that deserve commentary. These issues range from product stability and compatibility to medical practi...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1929119/ https://www.ncbi.nlm.nih.gov/pubmed/17608954 http://dx.doi.org/10.1186/1476-7961-5-3 |
| _version_ | 1782134263674568704 |
|---|---|
| author | Behrmann, Jason |
| author_facet | Behrmann, Jason |
| author_sort | Behrmann, Jason |
| collection | PubMed |
| description | While biotechnology-derived allergen therapeutics show promise in improving the safety of immunotherapy, they may prove to have additional benefits in comparison to conventional allergenic extracts that deserve commentary. These issues range from product stability and compatibility to medical practice issues, which will be the focus of this article. |
| format | Text |
| id | pubmed-1929119 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2007 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-19291192007-07-21 Looking ahead at the potential benefits of biotechnology-derived allergen therapeutics Behrmann, Jason Clin Mol Allergy Commentary While biotechnology-derived allergen therapeutics show promise in improving the safety of immunotherapy, they may prove to have additional benefits in comparison to conventional allergenic extracts that deserve commentary. These issues range from product stability and compatibility to medical practice issues, which will be the focus of this article. BioMed Central 2007-07-04 /pmc/articles/PMC1929119/ /pubmed/17608954 http://dx.doi.org/10.1186/1476-7961-5-3 Text en Copyright © 2007 Behrmann; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Commentary Behrmann, Jason Looking ahead at the potential benefits of biotechnology-derived allergen therapeutics |
| title | Looking ahead at the potential benefits of biotechnology-derived allergen therapeutics |
| title_full | Looking ahead at the potential benefits of biotechnology-derived allergen therapeutics |
| title_fullStr | Looking ahead at the potential benefits of biotechnology-derived allergen therapeutics |
| title_full_unstemmed | Looking ahead at the potential benefits of biotechnology-derived allergen therapeutics |
| title_short | Looking ahead at the potential benefits of biotechnology-derived allergen therapeutics |
| title_sort | looking ahead at the potential benefits of biotechnology-derived allergen therapeutics |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1929119/ https://www.ncbi.nlm.nih.gov/pubmed/17608954 http://dx.doi.org/10.1186/1476-7961-5-3 |
| work_keys_str_mv | AT behrmannjason lookingaheadatthepotentialbenefitsofbiotechnologyderivedallergentherapeutics |